ORCHPHARMA Stock Overview
A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for ORCHPHARMA from our risk checks.
Orchid Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,520.95 |
| 52 Week High | ₹1,590.00 |
| 52 Week Low | ₹432.05 |
| Beta | 2.35 |
| 11 Month Change | 7.28% |
| 3 Month Change | 58.51% |
| 1 Year Change | 176.29% |
| 33 Year Change | 275.50% |
| 5 Year Change | n/a |
| Change since IPO | 8,349.72% |
Recent News & Updates
Recent updates
Earnings Tell The Story For Orchid Pharma Limited (NSE:ORCHPHARMA) As Its Stock Soars 26%
Jul 29
We Ran A Stock Scan For Earnings Growth And Orchid Pharma (NSE:ORCHPHARMA) Passed With Ease
Jun 12Orchid Pharma Limited's (NSE:ORCHPHARMA) Intrinsic Value Is Potentially 17% Below Its Share Price
May 08Orchid Pharma Limited's (NSE:ORCHPHARMA) P/S Is Still On The Mark Following 72% Share Price Bounce
Feb 28Does Orchid Pharma (NSE:ORCHPHARMA) Have A Healthy Balance Sheet?
Feb 06Orchid Pharma Limited (NSE:ORCHPHARMA) Looks Just Right With A 33% Price Jump
Dec 18Shareholder Returns
| ORCHPHARMA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 10.1% | 2.4% | 1.0% |
| 1Y | 176.3% | 60.9% | 44.8% |
Return vs Industry: ORCHPHARMA exceeded the Indian Pharmaceuticals industry which returned 60.9% over the past year.
Return vs Market: ORCHPHARMA exceeded the Indian Market which returned 44.8% over the past year.
Price Volatility
| ORCHPHARMA volatility | |
|---|---|
| ORCHPHARMA Average Weekly Movement | 7.6% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.4% |
Stable Share Price: ORCHPHARMA's share price has been volatile over the past 3 months.
Volatility Over Time: ORCHPHARMA's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 871 | Manish Dhanuka | www.orchidpharma.com |
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services.
Orchid Pharma Limited Fundamentals Summary
| ORCHPHARMA fundamental statistics | |
|---|---|
| Market cap | ₹77.14b |
| Earnings (TTM) | ₹1.12b |
| Revenue (TTM) | ₹8.81b |
68.8x
P/E Ratio8.8x
P/S RatioIs ORCHPHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ORCHPHARMA income statement (TTM) | |
|---|---|
| Revenue | ₹8.81b |
| Cost of Revenue | ₹5.41b |
| Gross Profit | ₹3.39b |
| Other Expenses | ₹2.27b |
| Earnings | ₹1.12b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | 22.10 |
| Gross Margin | 38.54% |
| Net Profit Margin | 12.73% |
| Debt/Equity Ratio | 11.6% |
How did ORCHPHARMA perform over the long term?
See historical performance and comparison